Trevor Kilpatrick (MBBS PhD FRACP) is a Professor of Neurology at The University of Melbourne and Clinical Director at the Florey Institute of Neuroscience and Mental Health; he is the leader of the MS Division at the Florey Institute of Neuroscience and Mental Health; is Head of the MS Unit at the Royal Melbourne Hospital and is a clinical neurologist with particular expertise in multiple sclerosis.
Professor Kilpatrick graduated with a Bachelor of Medicine, Bachelor of Surgery from the University of Melbourne in 1982 and then went on to specialise in neurology.
He undertook graduate studies at The University of Melbourne and gained a Doctor of Philosophy in 1993. Appointments at The Salk Institute for Biological Studies (La Jolla, USA), Institute of Neurology (London, UK) and The National Hospital and Moorfields Eye Hospital (London, UK) followed. In 1995, he returned to Melbourne as the Viertel Senior Medical Research Fellow at the Walter & Eliza Hall Institute for Medical Research and as the Head of the Melbourne Multiple Sclerosis Research Unit at the Royal Melbourne Hospital. Professor Kilpatrick has been the recipient of the Sunderland Award (1994), AMRAD Postdoctoral Award (1995), inaugural Leonard Cox Award (2000), Bethlehem Griffiths Research Foundation Award for Medical Research (2004), the Australian Museum’s Jamie Callachor Eureka Prize for Medical Research (2008), the Stephen C. Reingold Research Award by the US MS National Multiple Sclerosis Society (2010) and most recently, (2013), Professor Kilpatrick was awarded the Bethlehem Griffiths Research Foundation Medal for outstanding leadership in medical research. Professor Kilpatrick has published widely with over 190 peer-reviewed publications in leading journals including Nature, Nature Genetics and Nature Medicine. His work is highly cited (>7130 times, H-index 40). He has played a lead role in assembling teams of biologists, geneticists, clinical researchers, epidemiologists and bioinformaticians to address major questions concerning the aetiology and pathogenesis of multiple sclerosis (MS) and most recently, his team has identified that the MerTK gene which encodes for one of the TAM receptors is a susceptibility gene for MS, providing an important link between predispostion to the disease and its pathogenesis. His other research interests include the study of genetic and environmental factors that contribute to MS as well as the translation of basic research discoveries to the clinic.